New Evidence Supporting the Use of Mineralocorticoid Receptor Blockers in Drug-Resistant Hypertension
about
Novel approaches for treating hypertensionMineralocorticoid receptor antagonists attenuate exaggerated exercise pressor reflex responses in hypertensive rats.Renal Artery Stenosis in Patients with Resistant Hypertension: Stent It or Not?Pannexin 1 Channels as an Unexpected New Target of the Anti-Hypertensive Drug Spironolactone.Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists.Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease: Rationale and Design of the AMBER Study
P2860
New Evidence Supporting the Use of Mineralocorticoid Receptor Blockers in Drug-Resistant Hypertension
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
New Evidence Supporting the Us ...... in Drug-Resistant Hypertension
@ast
New Evidence Supporting the Us ...... in Drug-Resistant Hypertension
@en
New Evidence Supporting the Us ...... in Drug-Resistant Hypertension
@nl
type
label
New Evidence Supporting the Us ...... in Drug-Resistant Hypertension
@ast
New Evidence Supporting the Us ...... in Drug-Resistant Hypertension
@en
New Evidence Supporting the Us ...... in Drug-Resistant Hypertension
@nl
prefLabel
New Evidence Supporting the Us ...... in Drug-Resistant Hypertension
@ast
New Evidence Supporting the Us ...... in Drug-Resistant Hypertension
@en
New Evidence Supporting the Us ...... in Drug-Resistant Hypertension
@nl
P2860
P921
P3181
P1476
New Evidence Supporting the Us ...... in Drug-Resistant Hypertension
@en
P2093
David J Webb
Hafid Narayan
P2860
P2888
P3181
P356
10.1007/S11906-016-0643-8
P407
P5008
P577
2016-04-01T00:00:00Z
P6179
1026655073